Enrolling Studies at STAT Research

Enrolling Studies

Below is the list of studies which are currently open for enrollment to those who qualify.

Study Name	Indication	Description	Location	Stipend	Apply
Abbvie M16-852	Giant Cell Arteritis	A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis	Vandalia, Ohio	$1900	Apply
PA0010	Psoriatic Arthritis	A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS	Vandalia, Ohio	$1925	Apply
PA0011	Psoriatic Arthritis	A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS	Vandalia, Ohio	$440	Apply
Contrast-1	Rheumatoid Arthritis	A 52-week, Phase 3, Multicenter, Randomized, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate	Vandalia, Ohio	$2900	Apply
Contrast-3	Rheumatoid Arthritis	Efficacy and safety of GSK3196165 versus placebo and sarilumab in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to biological DMARDs and/or Janus Kinase inhibitors.	Vandalia, Ohio	$1350	Apply
DYV-702 (Allen)	Gout	A randomized, double-blinded, placebo-controlled study of the efficacy and safety of DYV700 for reducing pain associated with Acute Gout Flares.	Vandalia, Ohio	$565	Apply
Dyve-702 (Ordway)	Gout	A randomized, double-blinded, placebo-controlled study of the efficacy and safety of DYV700 for reducing pain associated with Acute Gout Flares.	Springboro, Ohio	$565	Apply
SEPRA 9535-4416	Type 2 Diabetes	Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Clinical Trial	Springboro, Ohio	$90	Apply
CAMELOT	COVID-19	Protocol Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Camostat Mesilate for the Treatment of Confirmed COVID-19 in Outpatients	Springboro, Ohio	$200	Apply
ACTIV-2	COVID-19	Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID)	Springboro, Ohio	$0	Apply
PSA-013	Psoriatic Arthritis	Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.	Springboro, Ohio	$500	Apply
M19-944	Axial Spondyloarthritis	A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis	Springboro, Ohio	$2900	Apply

Upcoming Studies

Here is a list of the studies which we are not currently enrolling but expect to begin soon...

We currently do not have an upcoming studies to report.

How long do studies typically remain open for enrollment?

Studies typically have an enrollment period of about 6-months to a year. Of course, some studies enrollment windows are much shorter or longer depending on the enrollment criteria.

How many patients get enrolled on a study?

Most studies we conduct are multi-center studies, meaning there are many sites enrolling the same study across the country or globally. At STAT Research, we typically have enrollment numbers between 1 to 10 per study.